ARCHIVES

NCI Raises New Questions About Duke Genomics Research, Cuts Assay From Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 18 | May 14, 2010

Download PDF Visit The Full Archive

Related Articles

Ohio State Schedules Workshop On CCOP

February 5, 1982

Enck New ACCC President, King President Elect

March 20, 1987

Adjuvant XELOX More Effective Than 5-FU/LV For Stage III Colon Cancer

January 29, 2010

DRCCA Organization Still Not Complete; Division Will Chemoprevention

October 3, 1980

Another Feasibility Study For Women’s Wealth Trial? Yes And No; It’s ‘Class Of 84’s” Adieu

December 14, 1990

Nexavar Phase III Trial Fails To Meet Primary Endpoint

June 29, 2012